2m 2m 2m 2m 2m 2m 2m
ZENAS BIOPHARMA (ZBIO)
NASDAQ
$20.21-$0.60 (-2.86%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.3BMarket Cap
- 119.64%1-Year Change
- BiotechnologyIndustry
ZENAS BIOPHARMA (ZBIO)
$20.21-$0.60 (-2.86%)
ZBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.80 | ||
Change | +$1.02 (+5.16%) | ||
Open | $20.20 | ||
High | $20.97 | ||
Low | $19.99 | ||
Previous Close | $19.78 | ||
Volume | 643,448 | ||
30-Day Average Volume | 650,385 | ||
1-Week Change | 11.17% | ||
1-Month Change | 9.65% | ||
1-Year Change | 119.64% | ||
3-Year Change | 107.58% | ||
5-Year Change | 107.58% | ||
Fundamentals | |||
Shares Outstanding | 63.1M | ||
Total Assets | $747.7M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$81.0M | ||
Free Cash Flow | -$75.2M | ||
EBIT | -$80.8M | ||
EBITDA | -$80.8M | ||
Net Working Capital | $669.0M | ||
EPS | -$1.46 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 108 | ||
P/B | 4 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/24/2019 | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 05/24/2018 | ||
Earnings & Revenue